頁籤選單縮合
題名 | 從用藥安全到用藥安全環境建構=From Pharmacovigilance to Pharmacovigilance Planning |
---|---|
作者姓名(中文) | 王惠珀; | 書刊名 | 藥學雜誌 |
卷期 | 27:1=106 2011.03[民100.03] |
頁次 | 頁2-9 |
分類號 | 418.1 |
關鍵詞 | 用藥安全的環境建構; 實証藥學; 用藥風險; 中草藥; 健康食品; 用藥盛行率; Xenobiotics; Polypharmacy; Co-medication; Complementary/alternative medicine; CAM; Traditional Chinese medicine; TCM; Nutraceuticals; Pharmacovigilance planning; |
語文 | 中文(Chinese) |
中文摘要 | 藥品係知識經濟產品,知識看不見,而看不見的危險最危險,因此知識經濟產品應從產品安全的思維轉型為知識風險的預防。本文闡述 (1)系統生物學的整合評估是當代實証藥學的主流思維; (2)外源物與身體間的夥伴關係及風險; (3)品質、安全及療效是預防知識經濟產品風險的準則; (4)藥物、食品等生技產品知識切割的非科學性; (5)藥品、中草藥及健康食品切割管理的盲點及與流行病學的因果關係; (6)國際協合組織從用藥安全到用藥安全體系環境建構的歷史演進及思維邏輯; (7)用藥安全應從產品安全 (pharmacovigilance)轉型到環境建構 (pharmacovigilance planning)。 |
英文摘要 | The concept of pharmacovigilance planning (PVP), initiated by the International Conference on Harmonization (ICH) in 2004, addressed an important conceptual change from individual product-oriented pharmacovigilance to a proactive risk prevention and minimization on medication. However, the implementation of PVP is a challenge in societies like Taiwan where irrational medication or comedication is prevalent. This report addresses the opinion on system building for safe medication in Taiwan. Aspects included are (1) the scientific basis of system biology that governs xenobiotics-host interaction; (2) the beauty and odds of xenobiotics in biological system; (3) non-biased risk-benefit assessment of xenobiotics to be used for medication purpose; (4) summary of public information regarding to the risk underlying co-medication of drugs with complementary/alternative medicine; (5) epidemiology of co-medication of medicine with complementary/alternative medicine. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。